Published in Mediators Inflamm on October 24, 2005
The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol (1988) 9.51
The tumor necrosis factor ligand and receptor families. N Engl J Med (1996) 4.49
Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med (1990) 2.62
Ultraviolet light induced injury: immunological and inflammatory effects. Immunol Cell Biol (2001) 1.86
Sources and measurement of ultraviolet radiation. Methods (2002) 1.44
Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol (1990) 1.42
IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J Invest Dermatol (1993) 1.21
Ultraviolet irradiation induces the production of multiple cytokines by human corneal cells. Invest Ophthalmol Vis Sci (1997) 1.15
Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J Immunol (2000) 1.13
Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol (1995) 1.02
Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice. J Invest Dermatol (1996) 1.00
Defective immune response and severe skin damage following UVB irradiation in interleukin-6-deficient mice. Immunology (1999) 0.98
Effects of solar radiation on the human immune system. J Photochem Photobiol B (2001) 0.91
A single exposure of solar simulated radiation suppresses contact hypersensitivity responses both locally and systemically in humans: quantitative studies with high-frequency ultrasound. J Photochem Photobiol B (1998) 0.88
Differential modulation of human epidermal Langerhans cell maturation by ultraviolet B radiation. J Immunol (1999) 0.87
Downregulation of CXCR-2 but not CXCR-1 expression by human keratinocytes by UVB. J Cell Physiol (2000) 0.86
In contrast to their murine counterparts, normal human keratinocytes and human epidermoid cell lines A431 and HaCaT fail to express IL-10 mRNA and protein. Clin Exp Immunol (1997) 0.86
Whole-body exposure to ultraviolet radiation results in increased serum interleukin-1 activity in humans. Lymphokine Res (1987) 0.86
Suppressed alloantigen presentation, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin. J Invest Dermatol (1999) 0.85
Ultraviolet B radiation-induced production of interleukin 1alpha and interleukin 6 in a human squamous carcinoma cell line is wavelength-dependent and can be inhibited by pharmacological agents. Br J Dermatol (1998) 0.82
Mechanisms underlying UV-induced immune suppression: implications for sunscreen design. Exp Dermatol (2002) 0.82
Determining the role of cytokines in UV-induced immunomodulation. Methods (2002) 0.80
Whole-body UVB (TL-01) or UVA-1 irradiation does not alter the levels of immunomodulatory cytokines in the serum of human volunteers. Photodermatol Photoimmunol Photomed (2004) 0.78
The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials (2011) 1.87
Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health. Br J Nutr (2013) 1.64
Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol (2011) 1.46
Association between statin use and lupus-like syndrome using spontaneous reports. Semin Arthritis Rheum (2011) 1.43
Status of nutrition and health claims in Europe. Arch Biochem Biophys (2010) 1.24
Lupus vulgaris: report of two cases. Int J Dermatol (2005) 1.19
The effect of chronic ultraviolet radiation on the human immune system. Photochem Photobiol (2008) 1.19
Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol (2013) 1.15
Environmental risk factors predisposing to the development of basal cell carcinoma. Dermatol Surg (2004) 1.11
Probiotics: immunomodulation and evaluation of safety and efficacy. Nutr Rev (2006) 1.09
1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin. Pol J Pharmacol (2003) 1.07
Transcriptomic profile indicative of immunotoxic exposure: in vitro studies in peripheral blood mononuclear cells. Toxicol Sci (2010) 1.05
The number and distribution of blood dendritic cells in the epidermis and dermis of healthy human subjects. Folia Histochem Cytobiol (2006) 1.03
Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression. Int J Food Microbiol (2006) 0.98
Sunlight exposure and (sero)prevalence of epidermodysplasia verruciformis-associated human papillomavirus. J Invest Dermatol (2004) 0.96
Prenatal exposure to polychlorinated biphenyls and dioxins from the maternal diet may be associated with immunosuppressive effects that persist into early childhood. Food Chem Toxicol (2012) 0.95
Dermatitis artefacta in a patient with paranoid syndrome. Acta Dermatovenerol Alp Pannonica Adriat (2007) 0.93
Persistent hematologic and immunologic disturbances in 8-year-old Dutch children associated with perinatal dioxin exposure. Environ Health Perspect (2003) 0.93
Functional foods and dietary supplements: products at the interface between pharma and nutrition. Eur J Pharmacol (2011) 0.91
Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus. Eur Cytokine Netw (2004) 0.91
Toxicogenomic profiles in relation to maternal immunotoxic exposure and immune functionality in newborns. Toxicol Sci (2012) 0.91
Combined occurrence of filaggrin mutations and IL-10 or IL-13 polymorphisms predisposes to atopic dermatitis. Exp Dermatol (2011) 0.90
Quality of life and satisfaction with life in SLE patients-the importance of clinical manifestations. Clin Rheumatol (2010) 0.90
The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population. Cell Mol Biol Lett (2004) 0.89
IL-1beta gene polymorphisms influence hepatitis B vaccination. Vaccine (2002) 0.89
Persistent improvement of previously recalcitrant Hailey-Hailey disease with electron beam radiotherapy. Acta Derm Venereol (2010) 0.88
Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice. Br J Nutr (2007) 0.87
Immunotoxic effects of chemicals: A matrix for occupational and environmental epidemiological studies. Am J Ind Med (2006) 0.87
Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients. Mediators Inflamm (2003) 0.87
Acetylation genotype and phenotype in patients with systemic lupus erythematosus. Pharmacol Rep (2006) 0.86
The status of in vitro toxicity studies in the risk assessment of nanomaterials. Nanomedicine (Lond) (2009) 0.86
The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis. Mediators Inflamm (2009) 0.86
Phase I, randomized, double-blind, placebo-controlled, multiple intravenous, dose-ascending study of sirukumab in cutaneous or systemic lupus erythematosus. Arthritis Rheum (2013) 0.86
Non-animal sensitization testing: state-of-the-art. Crit Rev Toxicol (2010) 0.86
Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients. Mediators Inflamm (2005) 0.85
Endocrine effects of hexabromocyclododecane (HBCD) in a one-generation reproduction study in Wistar rats. Toxicol Lett (2008) 0.85
An enhanced risk of basal cell carcinoma is associated with particular polymorphisms in the VDR and MTHFR genes. Exp Dermatol (2011) 0.85
Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development? Arch Dermatol Res (2007) 0.85
Effective treatment of nodular amyloidosis with carbon dioxide laser. J Cutan Med Surg (2012) 0.85
Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approach. PLoS One (2012) 0.84
Global gene expression analysis in cord blood reveals gender-specific differences in response to carcinogenic exposure in utero. Cancer Epidemiol Biomarkers Prev (2012) 0.84
Protective effect of the KIR2DS1 gene in atopic dermatitis. Gene (2013) 0.84
[Medical and legal aspects of smoking]. Pol Merkur Lekarski (2012) 0.84
Proinflammatory interferon-gamma--inducing monokines (interleukin-12, interleukin-18, interleukin-15)--serum profile in patients with systemic lupus erythematosus. Eur Cytokine Netw (2002) 0.83
Exposure of Jurkat cells to bis (tri-n-butyltin) oxide (TBTO) induces transcriptomics changes indicative for ER- and oxidative stress, T cell activation and apoptosis. Toxicol Appl Pharmacol (2011) 0.83
Support of drug therapy using functional foods and dietary supplements: focus on statin therapy. Br J Nutr (2010) 0.83
Circulating proangiogenic molecules PIGF, SDF-1 and sVCAM-1 in patients with systemic lupus erythematosus. Eur Cytokine Netw (2007) 0.83
Developmental immunotoxicity of methylmercury: the relative sensitivity of developmental and immune parameters. Toxicol Sci (2010) 0.83
The importance of dietary control in the development of a peanut allergy model in Brown Norway rats. Methods (2007) 0.83
The effects of deoxynivalenol on gene expression in the murine thymus. Toxicol Appl Pharmacol (2010) 0.82
Vitamin D serum level changes in psoriatic patients treated with narrowband ultraviolet B phototherapy are related to the season of the irradiation. Photodermatol Photoimmunol Photomed (2011) 0.82
[Quality of life predictors among patients suffering from systemic lupus erythematosus]. Przegl Lek (2006) 0.82
Overlapping gene expression profiles of model compounds provide opportunities for immunotoxicity screening. Toxicol Appl Pharmacol (2007) 0.81
Respiratory sensitization: advances in assessing the risk of respiratory inflammation and irritation. Toxicol In Vitro (2011) 0.81
[Prevalence of autoantibodies directed against 1,25(OH)2D3 in patients with systemic lupus erythematosus]. Pol Merkur Lekarski (2010) 0.81
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis. Clin Rheumatol (2006) 0.81
Probiotics and prebiotics: health claim substantiation. Microb Ecol Health Dis (2012) 0.81
Serum concentration of interleukin-6 is increased both in active and remission stages of pemphigus vulgaris. Mediators Inflamm (2008) 0.81
Gene expression profiling of Bis(tri-n-butyltin)oxide (TBTO)-induced immunotoxicity in mice and rats. J Immunotoxicol (2006) 0.81
Developmental immunotoxicity of ethanol in an extended one-generation reproductive toxicity study. Arch Toxicol (2012) 0.81
Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol (2013) 0.81
IL-17 expression in dermatitis herpetiformis and bullous pemphigoid. Mediators Inflamm (2013) 0.80
Relative sensitivity of developmental and immune parameters in juvenile versus adult male rats after exposure to di(2-ethylhexyl) phthalate. Toxicol Appl Pharmacol (2012) 0.80
The respiratory local lymph node assay as a tool to study respiratory sensitizers. Toxicol Sci (2008) 0.80
Pathogenic activity of circulating anti-desmoglein-3 autoantibodies isolated from pemphigus vulgaris patients. Arch Med Sci (2012) 0.80
Repeated suberythemal UVB preexposure protects against high-dose UVB-induced expression of vitamin D receptor protein in human Skin. J Invest Dermatol (2011) 0.80
[Concentration of selected cytokines in serum of patients with acne rosacea]. Przegl Lek (2008) 0.80
[Neurological disorders in systemic lupus erythematosus patients]. Pol Merkur Lekarski (2009) 0.80
Risk factors in Central Poland for the development of superficial and nodular basal cell carcinomas. Arch Med Sci (2010) 0.80
Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms. Clin Rheumatol (2006) 0.80
Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users. Pharmacoepidemiol Drug Saf (2012) 0.80
Toxicogenomics-based identification of mechanisms for direct immunotoxicity. Toxicol Sci (2013) 0.79
Interleukin 4 plasma levels in psoriasis vulgaris patients. Med Sci Monit (2004) 0.79
Correlations between concentrations of interleukin (IL)-17A, IL-17B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients. Eur Cytokine Netw (2013) 0.79
Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohort. Environ Health Perspect (2013) 0.79
Influence of the macrophage bacterial resistance gene, Nramp1 (Slc11a1), on the induction of allergic asthma in the mouse. FASEB J (2003) 0.79
The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis. Mediators Inflamm (2005) 0.79
Suppression of different phases of systemic contact hypersensitivity by urocanic acid oxidation products. Photochem Photobiol (2004) 0.79
Protein expression profiling of mouse thymoma cells upon exposure to the trichothecene deoxynivalenol (DON): implications for its mechanism of action. J Immunotoxicol (2010) 0.79
Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis. Mediators Inflamm (2006) 0.79
Contact hypersensitivity to haptens of the European standard series and corticosteroid series in the population of adolescents and adults with atopic dermatitis. Dermatitis (2014) 0.78
Characterization of the modes of action of deoxynivalenol (DON) in the human Jurkat T-cell line. J Immunotoxicol (2014) 0.78
Plaque form of warty dyskeratoma - acantholytic dyskeratotic acanthoma. J Cutan Pathol (2007) 0.78
Detection of immunotoxicity using T-cell based cytokine reporter cell lines ("Cell Chip"). Toxicology (2005) 0.78
Proteomic analysis of mouse thymoma EL4 cells treated with bis(tri-n-butyltin)oxide (TBTO). J Immunotoxicol (2009) 0.78
In vitro assessment of sensitizing activity of low molecular weight compounds. Toxicol Appl Pharmacol (2005) 0.78
Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol. J Invest Dermatol (2011) 0.78
Epidermal cis-urocanic acid levels correlate with lower specific cellular immune responses after hepatitis B vaccination of ultraviolet B-exposed humans. Photochem Photobiol (2003) 0.78
Transcriptome analysis of the human T lymphocyte cell line Jurkat and human peripheral blood mononuclear cells exposed to deoxynivalenol (DON): New mechanistic insights. Toxicol Appl Pharmacol (2012) 0.78